Georg Pilz

Research output

Research output per year 2007 2008 2010 2011 2012 2013 2014 2015 2016 2017 2018 2020 2021 2022 2023

• 34 Original Article (Journal)
• 16 published Abstract (Journal)
• 6 Review article
• 5 Case report
• 5 More
  • 4 Letter to the editor
  • 1 Poster

Research output per year

Research output per year

Search results

• 2023

  Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study.

  Foettinger, F., Pilz, G. (Co-author), Wipfler, P. (Co-author), Harrer, A. (Co-author), Kern, J. M. (Co-author), Trinka, E. (Co-author) & Moser, T. (Last author), 31 Mar 2023, In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24, 7

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  2 Citations (Web of Science)
• 2022

  Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study.

  Moser, T. (First author), OSullivan, C. (Co-author), Otto, F. (Co-author), Hitzl, W. (Co-author), Pilz, G. (Co-author), Schwenker, K. (Co-author), Mrazek, C. (Co-author), Haschke-Becher, E. (Co-author), Trinka, E. (Co-author), Wipfler, P. (Co-author) & Harrer, A. (Last author), 22 Apr 2022, In: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. 15, p. 17562864221092092

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  6 Citations (Web of Science)

• Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications - A pilot study.

  Moser, T. (First author), Otto, F. (Co-author), O"Sullivan, C. (Co-author), Hitzl, W. (Co-author), Pilz, G. (Co-author), Harrer, A. (Co-author), Trinka, E. (Co-author) & Wipfler, P. (Last author), 24 Jan 2022, In: Multiple Sclerosis and Related Disorders. 59, p. 103560

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  11 Citations (Web of Science)
• 2021

  Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine.

  Radlberger, R. F. (First author), Sakic, I., Moser, T. (Co-author), Pilz, G. (Co-author), Harrer, A. (Co-author) & Wipfler, P. (Last author), 2021, In: Multiple Sclerosis and Related Disorders. 48, p. 102727

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  5 Citations (Web of Science)

• Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy.

  Moser, T. (First author), OSullivan, C., Puttinger, C., Feige, J. (Co-author), Pilz, G. (Co-author), Haschke-Becher, E. (Co-author), Cadamuro, J. (Co-author), Oberkofler, H., Hitzl, W. (Co-author), Harrer, A. (Co-author), Kraus, J. (Co-author), Trinka, E. (Co-author) & Wipfler, P. (Last author), 2021, In: BIOMEDICINES. 9, 11

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  6 Citations (Web of Science)

• Tetravalent Influenza Vaccine Is Not Associated With Neuroaxonal Damage in Multiple Sclerosis Patients.

  Moser, T. (First author), Seiberl, M. (Co-author), Feige, J. (Co-author), Bieler, L., Radlberger, R. F. (Co-author), OSullivan, C., Pilz, G. (Co-author), Harrer, A. (Co-author), Schwenker, K. (Co-author), Haschke-Becher, E. (Co-author), Machegger, L. (Co-author), Grimm, J. (Co-author), Redlberger-Fritz, M., Buchmann, A., Khalil, M., Kvas, E., Trinka, E. (Co-author) & Wipfler, P. (Last author), Aug 2021, In: FRONTIERS IN IMMUNOLOGY. 12, p. 718895

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  5 Citations (Web of Science)

• The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF

  Harrer, C., Otto, F. (Co-author), Pilz, G. (Co-author), Haschke-Becher, E. (Co-author), Trinka, E. (Co-author), Hitzl, W. (Co-author), Wipfler, P. (Last author) & Harrer, A. (Last author), 26 Aug 2021, In: Fluids and Barriers of the CNS. 18, 1, p. 40

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  13 Citations (Web of Science)
• 2020

  Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.

  Pilz, G. (First author), Steger, R., Wipfler, P. (Co-author), Otto, F. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Trinka, E. (Co-author) & Harrer, A. (Last author), 2020, In: JOURNAL OF NEUROIMMUNOLOGY . 338, p. 577087

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  10 Citations (Web of Science)

• Chemokine CXCL13 in serum, CSF and blood-CSF barrier function: evidence of compartment restriction.

  Pilz, G. (First author), Sakic, I., Wipfler, P. (Co-author), Kraus, J. (Co-author), Haschke-Becher, E. (Co-author), Hitzl, W. (Co-author), Trinka, E. (Co-author) & Harrer, A. (Last author), 2020, In: Fluids and Barriers of the CNS. 17, 1, p. 7

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  15 Citations (Web of Science)

• Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study.

  Mylonaki, E., Harrer, A. (Co-author), Pilz, G. (Co-author), Stalzer, P., Otto, F. (Co-author), Trinka, E. (Co-author) & Wipfler, P. (Last author), 30 Mar 2020, In: JOURNAL OF CLINICAL VIROLOGY . 127, p. 104340

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  10 Citations (Web of Science)
• 2019

  Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.

  Pilz, G. (First author), Wipfler, P. (Co-author), Otto, F. (Co-author), Hitzl, W. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Trinka, E. (Co-author) & Harrer, A. (Last author), 19 Jan 2019, In: JOURNAL OF NEUROINFLAMMATION. 16, 1, p. 13

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  12 Citations (Web of Science)

• Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes.

  Leitinger, M. (First author), Trinka, E. (First author), Giovannini, G., Zimmermann, G. J. (Co-author), Florea, C., Rohracher, A. (Co-author), Kalss, G. (Co-author), Neuray, C., Kreidenhuber, R. (Co-author), Höfler, J. (Co-author), Kuchukhidze, G. (Co-author), Granbichler, C., Dobesberger, J. (Co-author), Novak, H. (Co-author), Pilz, G. (Co-author), Meletti, S. & Siebert, U., 2019, In: EPILEPSIA. 60, 1, p. 53-62

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  151 Citations (Web of Science)
• 2018

  Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit: A single-center audit of 30 patients.

  Rohracher, A. (First author), Kalss, G. (Co-author), Neuray, C., Höfler, J. (Co-author), Dobesberger, J. (Co-author), Kuchukhidze, G. (Co-author), Kreidenhuber, R. (Co-author), Florea, C., Thomschewski, A. (Co-author), Novak, H. (Co-author), Pilz, G. (Co-author), Leitinger, M. (Co-author) & Trinka, E. (Last author), 2018, In: EPILEPSIA. 59 Suppl 2, p. 234-242

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  29 Citations (Web of Science)
• 2017

  From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

  Harrer, A. (First author), Pilz, G. (Co-author), Oppermann, K. (Co-author), Sageder, M., Afazel, S., Haschke-Becher, E. (Co-author), Rispens, T., de Vries, A., McCoy, M. R. (Co-author), Stevanovic, V., Hitzl, W. (Co-author), Trinka, E. (Co-author), Kraus, J. (Co-author), Sellner, J. (Co-author) & Wipfler, P. (Last author), 2017, In: CLINICAL IMMUNOLOGY . 176, p. 87-93

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  5 Citations (Web of Science)
• 2016

  (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.

  Höfler, J. (First author), Rohracher, A. (Co-author), Kalss, G. (Co-author), Zimmermann, G. J. (Co-author), Dobesberger, J. (Co-author), Pilz, G. (Co-author), Leitinger, M. (Co-author), Kuchukhidze, G. (Co-author), Butz, K. H. G. (Co-author), Taylor, A., Novak, H. (Co-author) & Trinka, E. (Last author), 2016, In: CNS DRUGS. 30, 9, p. 869-876

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  43 Citations (Web of Science)

• Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

  Karamyan, A., Dünser, M. (Co-author), Wiebe, D. J., Pilz, G. (Co-author), Wipfler, P. (Co-author), Chroust, V. (Co-author), Novak, H. (Co-author), Hauer, L. (Co-author), Trinka, E. (Co-author) & Sellner, J. (Last author), 2016, In: PLOS ONE. 11, 5, p. e0155795

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  11 Citations (Web of Science)
• 2015

  Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

  Harrer, A. (First author), Wipfler, P. (Co-author), Pilz, G. (Co-author), Oppermann, K. (Co-author), Haschke-Becher, E. (Co-author), Afazel, S., Kraus, J. (Co-author), Trinka, E. (Co-author) & Sellner, J. (Last author), 2015, In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 16, 9, p. 21832-21845

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  6 Citations (Web of Science)

• High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

  Harrer, A. (First author), Pilz, G. (Co-author), Wipfler, P. (Co-author), Oppermann, K. (Co-author), Sellner, J. (Co-author), Hitzl, W. (Co-author), Haschke-Becher, E. (Co-author), Afazel, S., Rispens, T., van der Kleij, D., Trinka, E. (Co-author) & Kraus, J. (Last author), 2015, In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 180, 3, p. 383-392

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  20 Citations (Web of Science)

• Perampanel in patients with refractory and super-refractory status epilepticus in a neurological intensive care unit.

  Rohracher, A. (First author), Höfler, J. (Co-author), Kalss, G. (Co-author), Leitinger, M. (Co-author), Kuchukhidze, G. (Co-author), Deak, I. (Co-author), Dobesberger, J. (Co-author), Novak, H. (Co-author), Pilz, G. (Co-author), Zerbs, A. (Co-author) & Trinka, E. (Last author), 2015, In: EPILEPSY & BEHAVIOR : E&B. 49, p. 354-358

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  53 Citations (Web of Science)

• Predicting outcome of status epilepticus.

  Leitinger, M. (First author), Kalss, G. (Co-author), Rohracher, A. (Co-author), Pilz, G. (Co-author), Novak, H. (Co-author), Höfler, J. (Co-author), Deak, I. (Co-author), Kuchukhidze, G. (Co-author), Dobesberger, J. (Co-author), Wakonig, A. (Co-author) & Trinka, E. (Last author), 2015, In: EPILEPSY & BEHAVIOR : E&B. 49, p. 126-130

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  37 Citations (Web of Science)
• 2014

  A routine-qualified flow cytometric method for the identification of multiple sclerosis patients with reduced therapy efficiency under natalizumab

  Oppermann, K. (First author), Harrer, A. (Co-author), Pilz, G. (Co-author), Wipfler, P. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Sellner, J. (Co-author), Deisenhammer, F., Trinka, E. (Co-author) & Kraus, J. (Last author), 2014, In: LaboratoriumsMedizin-Journal of Laboratory Medicine. 38, 1, p. 17-23

  Research output: Contribution to journal › Original Article (Journal) › peer-review

• Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

  Wipfler, P. (First author), Harrer, A. (First author), Pilz, G. (Co-author), Oppermann, K. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Sellner, J. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2014, In: ACTA NEUROLOGICA SCANDINAVICA . 129, 3, p. e12-e15

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  19 Citations (Web of Science)
• 2013

  Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy.

  Harrer, A. (First author), Tumani, H., Niendorf, S., Lauda, F., Geis, C., Weishaupt, A., Kleinschnitz, C., Rauer, S., Kuhle, J., Stangel, M., Weber, F., Uhr, M., Linnebank, M., Wildemann, B., Jarius, S., Guger, M., Ayzenberg, I., Chan, A., Zettl, U. & Wiendl, H. & 4 others, Pilz, G. (Co-author), Hitzl, W. (Co-author), Weber, J. R. & Kraus, J. (Last author), 2013, In: MULTIPLE SCLEROSIS . 19, 9, p. 1209-1212

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  60 Citations (Web of Science)

• Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.

  Wipfler, P. (First author), Heikkinen, A., Harrer, A. (Co-author), Pilz, G. (Co-author), Kunz, A. (Co-author), Golaszewski, S. (Co-author), Reuss, R., Oschmann, P. & Kraus, J. (Last author), 2013, In: JOURNAL OF NEUROLOGY . 260, 1, p. 221-227

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  20 Citations (Web of Science)

• Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

  Sellner, J. (First author), Koczi, W., Harrer, A. (Co-author), Oppermann, K. (Co-author), Obregon-Castrillo, E., Pilz, G. (Co-author), Wipfler, P. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2013, In: CLINICAL AND EXPERIMENTAL IMMUNOLOGY . 173, 3, p. 381-389

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  25 Citations (Web of Science)

• Tumefactive MS lesions under fingolimod: a case report and literature review.

  Pilz, G. (First author), Harrer, A. (First author), Wipfler, P. (Co-author), Oppermann, K. (Co-author), Sellner, J. (Co-author), Fazekas, F., Trinka, E. (Co-author) & Kraus, J. (Last author), 2013, In: NEUROLOGY . 81, 19, p. 1654-1658

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  59 Citations (Web of Science)
• 2012

  Flow cytometry and drug monitoring of natalizumab saturation of immune cells in multiple sclerosis

  Harrer, A. (First author), Oppermann, K. (Co-author), Pilz, G. (Co-author), Wipfler, P. (Co-author), Afazel, S., Haschke-Becher, L., Trinka, E. (Co-author) & Kraus, J. (Last author), 2012, In: LaboratoriumsMedizin-Journal of Laboratory Medicine. 36, 6, p. 377-382

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  2 Citations (Web of Science)

• Future relevance of CSF biomarkers in modern MS treatment

  Pilz, G. (First author), Wipfler, P. (First author), Harrer, A. (Co-author), Holl, B. (Co-author), Oppermann, K. (Co-author), Golaszewski, S. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2012, In: LaboratoriumsMedizin-Journal of Laboratory Medicine. 36, 6, p. 383-388

  Research output: Contribution to journal › Original Article (Journal) › peer-review

• Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

  Harrer, A. (First author), Pilz, G. (First author), Einhaeupl, M., Oppermann, K. (Co-author), Hitzl, W. (Co-author), Wipfler, P. (Co-author), Sellner, J. (Co-author), Golaszewski, S. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2012, In: PLOS ONE. 7, 2, p. e31784

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  19 Citations (Web of Science)

• Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.

  Pilz, G. (First author), Harrer, A. (Co-author), Oppermann, K. (Co-author), Wipfler, P. (Co-author), Golaszewski, S. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2012, In: MULTIPLE SCLEROSIS . 18, 4, p. 506-509

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  9 Citations (Web of Science)
• 2011

  Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.

  Wipfler, P. (First author), Oppermann, K. (Co-author), Pilz, G. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Harrer, A. (Co-author), Huemer, M. (Co-author), Kunz, A., Golaszewski, S. (Co-author), Staffen, W. (Co-author), Ladurner, G. & Kraus, J. (Last author), 2011, In: MULTIPLE SCLEROSIS . 17, 1, p. 16-23

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  27 Citations (Web of Science)

• Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.

  Harrer, A. (First author), Wipfler, P. (First author), Einhaeupl, M., Pilz, G. (Co-author), Oppermann, K. (Co-author), Hitzl, W. (Co-author), Afazel, S., Haschke-Becher, E. (Co-author), Strasser, P. (Co-author), Trinka, E. (Co-author) & Kraus, J. (Last author), 2011, In: JOURNAL OF NEUROIMMUNOLOGY . 234, 1-2, p. 148-154

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  27 Citations (Web of Science)
• 2010

  Relationship between thrombin generation and carotid intima-media thickness.

  Bernhard, H. (First author), Wipfler, P. (Co-author), Leschnik, B., Novak, M., Kraus, J. (Co-author), Pilz, G. (Co-author), Ladurner, G. & Muntean, W., 2010, In: HÄMOSTASEOLOGIE. 30 Suppl 1, p. S168-S171

  Research output: Contribution to journal › Original Article (Journal) › peer-review

  18 Citations (Web of Science)
• 2007

  Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells.

  Falkensammer, B., Pilz, G., Bektić, J., Imwidthaya, P., Jöhrer, K., Speth, C., Lass-Flörl, C., Dierich, M. P. & Würzner, R., 2007, In: MYCOSES . 50, 3, p. 172-177

  Research output: Contribution to journal › Original Article (Journal) › peer-review
  15 Citations (Web of Science)